Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Tuberculosis

  • your selections
Clear Search

Filter Results

date

Tags

  • results
MSF Releases Report On TB Prevention, Treatment R&D Landscape

“Without a new approach to developing and pricing new tuberculosis (TB) medicines, the global TB response will be unable to deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant tuberculosis (DR-TB),” Médecins Sans Frontières (MSF) warned Wednesday at the 44th Union World Conference on Lung…

Expert Cautious Over Global Fund’s New TB/HIV Funding Strategy, Devex Reports

“Groups advocating for [tuberculosis (TB)] elimination are hailing a new Global Fund proposed strategy that could raise coverage of the disease’s treatment, but an [unnamed] expert warns it entails some risks,” Devex reports. The recommendation — “that countries with high TB and HIV co-infection applying for Global Fund support only…

European Leaders Must Make Good On Commitments To Fight TB

“One third of the world’s population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and one tenth of these people will become sick from the illness during their lifetime,” WHO Regional Director for Europe Zsuzsanna Jakab writes in the Huffington Post’s “The Big Push” blog. “Today we are…

NPR Examines Reemergence Of Tuberculosis

NPR’s Shots blog examines the reemergence of tuberculosis in some parts of the world as well as the history of the disease, including in the U.S., as part of its continued coverage on the disease. “TB is not at all treated with the diligence that it should be,” Mel Spigelman, president and…

New Issue Of Lancet Global Health Available Online

Writing in a Lancet Global Health editorial, journal editor Zoë Mullan describes the content of the August 2013 issue. “Osman Sankoh and fellow INDEPTH Network colleagues announce a new freely accessible repository of Health and Demographic Surveillance System data generated by its member centers across Africa, Asia, and the Pacific”;…

Blog Describes Status Of Two Experimental TB Drugs

The Center for Global Health Policy’s “Science Speaks” blog reports on the status of two experimental drugs to treat tuberculosis. “On Friday, the European Medicines Agency issued a statement refusing authorization to market [the experimental drug] delamanid for treatment of drug-resistant tuberculosis, saying the benefits of delamanid ‘had not been…

Global Health Agencies Must Do More To Combat Drug-Resistant TB In North Korea

“Tuberculosis has long been recognized as one of the biggest public health problems in North Korea, but there is a disturbing new development: much of the TB in North Korea is resistant to regular antibiotics,” K.J. Seung, deputy director for the Partners In Health project in Lesotho and a physician…

Pharmaceutical Industry, International Community Must Place Drug-Resistant TB On Agenda

Writing in The Guardian’s “Global Development Professionals Network” blog, Emily Wise, a doctor volunteering with Médecins Sans Frontières/Doctors Without Borders (MSF) in Karakalpakstan, Uzbekistan, an area where drug-resistant tuberculosis (TB) is endemic, examines the conflict surrounding the treatment of the disease with a drug that can cause depression and suicidal…

Former Prisoner Aims To Reform TB Prevention Efforts In South African Prisons

The Wall Street Journal examines how a former prisoner in South Africa “is forcing [the country] this year to intensify its fight against [tuberculosis (TB),] a disease that has breached jail cells, defied international borders, and grown increasingly drug resistant.” Arrested “on accusations of money laundering and trafficking counterfeit passports…

Study Examines Potential Impact Of PEPFAR Funding On TB Incidence, Mortality

The Center for Global Health Policy’s “Science Speaks” blog reports on a study published last week in the Journal of Infectious Diseases that compared data from 12 PEPFAR focus countries with data from 29 control countries to examine the potential impact of PEPFAR funding on the tuberculosis (TB) epidemic in…